TABLE 5.

Association of Hospital-Level and Patient-Level Factors With Testing and Prophylaxis

Factor	Testing		Prophylaxis
	OR	95% CI	OR	95% CI
Hospital level
Pathway	0.88	0.46–1.68	1.46	1.15–1.86
Team	1.30	0.63–2.69	0.83	0.61–1.12
Region
Midwest	Referent	Referent	Referent	Referent
Northeast	0.76	0.25–2.35	1.04	0.69–1.56
South	0.61	0.29–1.26	0.77	0.55–1.08
West	0.71	0.23–2.18	0.69	0.43–1.10
Patient level
Age, y
12	Referent	Referent	Referent	Referent
13	1.28	1.15–1.43	1.45	1.32–1.60
14	1.39	1.20–1.61	1.67	1.39–2.00
15	1.62	1.34–1.97	2.12	1.63–2.76
16–18	1.47	1.18–1.83	1.86	1.45–2.40
Gender
Male	Referent	Referent	Referent	Referent
Female	1.08	0.86–1.37	2.01	1.56–2.60
Race/ethnicity
Non-Hispanic white	Referent	Referent	Referent	Referent
Non-Hispanic black	1.23	0.96–1.58	1.09	0.93–1.29
Hispanic	0.82	0.59–1.15	0.71	0.47–1.08
Other	0.96	0.72–1.28	1.11	0.92–1.35
Insurance
Private	Referent	Referent	Referent	Referent
Public	0.92	0.72–1.18	0.95	0.82–1.09
Uninsured	1.19	0.85–1.67	1.10	0.76–1.59
Other	0.94	0.70–1.26	0.87	0.58–1.31
Discharge year	1.10	0.97–1.24	1.10	1.03–1.16

Results generated from logistic regression models accounting for clustering by hospital. Testing included testing for chlamydia, gonorrhea, and pregnancy if female. Prophylaxis included treatment of chlamydia and gonorrhea and emergency contraception if female. The year the patient was discharged from the ED (2004 to 2013) was included as a continuous variable.